Document Detail


Interpretation of reverse redistribution of 99mTc-tetrofosmin in patients with acute myocardial infarction.
MedLine Citation:
PMID:  12458393     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Reverse redistribution (RR) of technetium-99m tetrofosmin (TF) in patients with acute myocardial infarction (AMI) has been considered a sign of salvaged myocardium. We examined the time evolution of the RR pattern during a 6-month period and the clinical implications of RR. TF myocardial SPET was performed in 22 patients 1 week, 1 month and 3-6 months after AMI. Myocardial images were obtained 30 min and 180 min after the injection of TF. Regional uptake of TF was rated using a four-point scoring system. RR was defined as an increase of more than 1 point in the regional score on images obtained at 180 min. Echocardiography was performed to assess regional wall motion at the same time as TF imaging. RR observed at 1 week tended to disappear after 1 month and 3-6 months. The incidence of regional wall motion abnormality was reduced in patients with RR compared with that in patients with fixed defects. Recovery of abnormal regional wall motion occurred earlier in segments with disappearance of RR than in those without disappearance of RR. It is concluded that RR may reflect salvaged myocardium and that disappearance of RR may indicate earlier recovery of salvaged myocardium.
Authors:
Yoshihide Hirata; Michitaka Takamiya; Noriyuki Kinoshita; Hiroyuki Yamada; Takatomo Shima; Hiroshi Miyazaki; Yoshio Kouno; Naohisa Sawada; Kenzou Sakamoto; Hiroki Sugihara
Related Documents :
6846153 - Enhanced detection of proximal right coronary artery stenosis with the additional analy...
21965153 - Relationship of contrast-enhanced magnetic resonance imaging-derived intramural scar di...
3154643 - The acute effects of intravenous nisoldipine on left ventricular function 24 to 72 hour...
Publication Detail:
Type:  Clinical Trial; Journal Article     Date:  2002-09-19
Journal Detail:
Title:  European journal of nuclear medicine and molecular imaging     Volume:  29     ISSN:  1619-7070     ISO Abbreviation:  Eur. J. Nucl. Med. Mol. Imaging     Publication Date:  2002 Dec 
Date Detail:
Created Date:  2002-11-29     Completed Date:  2003-08-15     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  101140988     Medline TA:  Eur J Nucl Med Mol Imaging     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1594-9     Citation Subset:  IM    
Affiliation:
Department of Cardiology, Kyoto First Red Cross Hospital, Kyoto, Japan. kissmeyh@gaia.eonet.ne.jp
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Angioplasty, Transluminal, Percutaneous Coronary
Female
Follow-Up Studies
Heart Ventricles / metabolism*,  radionuclide imaging,  ultrasonography
Humans
Male
Metabolic Clearance Rate
Middle Aged
Myocardial Infarction / metabolism*,  radionuclide imaging*,  therapy,  ultrasonography
Myocardial Reperfusion
Organophosphorus Compounds / diagnostic use*,  pharmacokinetics*
Organotechnetium Compounds / diagnostic use*,  pharmacokinetics*
Predictive Value of Tests
Radiopharmaceuticals / diagnostic use,  pharmacokinetics
Single-Blind Method
Tissue Distribution
Tissue Survival
Tomography, Emission-Computed, Single-Photon / methods
Treatment Outcome
Chemical
Reg. No./Substance:
0/Organophosphorus Compounds; 0/Organotechnetium Compounds; 0/Radiopharmaceuticals; 0/technetium Tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane
Comments/Corrections
Comment In:
Eur J Nucl Med Mol Imaging. 2003 May;30(5):798-9   [PMID:  12658508 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardiac phantom measurement validating the methodology for a cardiac multi-centre trial with positro...
Next Document:  Variability of insulin-stimulated myocardial glucose uptake in healthy elderly subjects.